Tag: the-pricey
-
Patent for J&J’s Remicade invalidated, cheaper version looms
A cheaper version of Johnson & Johnson's top-selling drug, the pricey rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled that a key patent …